BioMed Research International / 2009 / Article / Tab 2

Research Article

Serodeconversion of HIV Antibody-Positive AIDS Patients Following Treatment with V-1 Immunitor

Table 2

Odds ratio of observed serodeconversion rate, that is, 23 out of 60,000 patients, in comparison to published incidence rate of erroneous HIV tests.

ReportObservedTotal numberOdds ratio with CI at 95%Two-sided value

[1]1135 000OR = 0.0193; CI = 0.002–0.1432
[1]1251 000OR = 0.0104; CI = 0.001–0.077
[2]61000 000OR = 0.0157; CI = 0.0064–0.038
[3]1100 000OR = 0.0261; CI = 0.004–0.1932
[4]311032OR = 78.362; CI = 45.53–134.86
[32]12.41000 000OR = 0.0324; CI = 0.0207–0.051

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.